PRESENT INSIGHTS INTO THE ETIOLOGY AND PATHOGENESIS OF MASTOPATHIES

dataset OA: green CC0
Full text JSON View on OpenAlex View at publisher

Abstract

Mastopathy, also known as fibrocystic breast disease, is one of the most prevalent benign breast disorders in women of reproductive age. Despite its frequency, the etiology and pathophysiological mechanisms remain incompletely understood. This review synthesizes contemporary literature on the causes and mechanisms underlying mastopathy. Hormonal imbalance, particularly an elevated estradiol-to-progesterone ratio and increased prolactin activity, emerges as a central factor in disease development. Genetic predispositions, including polymorphisms in FSH receptor and estrogen receptor genes, are associated with higher susceptibility. Immune-mediated mechanisms, highlighted by lymphocytic infiltration, myofibroblast activation, and autoimmune links in diabetic mastopathy, further contribute to disease progression. Structural alterations in breast tissue, such as epithelial and stromal proliferation with fibrosis, are driven by hormonal and immunologic factors. Lifestyle and reproductive history also play modifying roles. Collectively, current evidence supports a multifactorial model of mastopathy involving endocrine, genetic, immunologic, and environmental influences. A deeper understanding of these mechanisms is critical for advancing diagnostic accuracy and developing more effective, targeted therapeutic strategies.
Full text 2,730 characters · extracted from oa-doi-fallback · click to expand
PRESENT INSIGHTS INTO THE ETIOLOGY AND PATHOGENESIS OF MASTOPATHIES Authors/Creators - 1. Asia International University, Bukhara, Uzbekistan Description Mastopathy, also known as fibrocystic breast disease, is one of the most prevalent benign breast disorders in women of reproductive age. Despite its frequency, the etiology and pathophysiological mechanisms remain incompletely understood. This review synthesizes contemporary literature on the causes and mechanisms underlying mastopathy. Hormonal imbalance, particularly an elevated estradiol-to-progesterone ratio and increased prolactin activity, emerges as a central factor in disease development. Genetic predispositions, including polymorphisms in FSH receptor and estrogen receptor genes, are associated with higher susceptibility. Immune-mediated mechanisms, highlighted by lymphocytic infiltration, myofibroblast activation, and autoimmune links in diabetic mastopathy, further contribute to disease progression. Structural alterations in breast tissue, such as epithelial and stromal proliferation with fibrosis, are driven by hormonal and immunologic factors. Lifestyle and reproductive history also play modifying roles. Collectively, current evidence supports a multifactorial model of mastopathy involving endocrine, genetic, immunologic, and environmental influences. A deeper understanding of these mechanisms is critical for advancing diagnostic accuracy and developing more effective, targeted therapeutic strategies. Files 2359-2369.pdf Files (363.4 kB) | Name | Size | Download all | |---|---|---| | md5:9a7d06b6fa917dec0d2ab5c383f61fa0 | 363.4 kB | Preview Download | Additional details References - Brkić, M., Djaković, I., Tomić, S., & Bulajić, M. (2018). Hormonal profiles in women with fibrocystic breast changes. Medicinski Pregled, 71(3-4), 89–94. https://doi.org/10.2298/MPNS1804089B - Camuto, P. M., Zetrenne, E., & Ponn, T. (2000). Diabetic mastopathy: a report of 5 cases and a review of the literature. Archives of Surgery, 135(10), 1190–1193. https://doi.org/10.1001/archsurg.135.10.1190 - Chen, L., Zhou, J., Zhang, M., & Zhu, Y. (2018). Epidemiological and histopathological features of fibrocystic breast disease: A comprehensive review. International Journal of Clinical and Experimental Pathology, 11(2), 1215–1223. - 4.Chopra, S., Bharti, A., & Yadav, R. (2023). Hormonal imbalance in benign breast disease: An observational study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 12(2), 356–361. https://doi.org/10.18203/2320-1770.ijrcog20230256 - Fraker, D. L., Patel, A., & Singh, A. (2023). Morphological changes and fibrotic pathways in mastopathy: A review. Journal of Breast Pathology, 45(2), 75–84.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-05-13T18:30:17.023456+00:00
License: CC0 · commercial use OK